Medication Administration Safety Measures

Key Points

  • Safety checks are grouped into four domains: patient identification, order verification, safe environment, and adverse-reaction monitoring.
  • At least two patient identifiers are required for every administration event.
  • Order verification includes completeness, allergy safety, and indication clarity (including PRN indications).
  • Environment controls reduce diversion, mix-ups, and interruption-related errors.

Equipment

  • MAR/EHR with CPOE order access
  • Patient armband and approved identifier references
  • Locked medication storage and narcotic access controls
  • Adverse-reaction monitoring and escalation tools

Procedure Steps

  1. Identify the patient with at least two unique identifiers and confirm against armband and MAR.
  2. Review the medication order for completeness, legibility, and internal consistency before administration.
  3. Verify allergy status and stop for prescriber clarification when a conflict is present.
  4. Validate drug indication, including explicit PRN trigger criteria and sequencing when multiple PRNs share one symptom.
  5. Use CPOE safeguards (interaction checks, dose-range prompts, hard stops) to detect preventable errors.
  6. Maintain safe environment controls: secure storage, restricted access, one-patient-at-a-time preparation, and immediate administration after preparation.
  7. Follow controlled-substance safeguards including double-lock storage and required count processes.
  8. Minimize interruptions by using no-talking medication zones and focused preparation workflow.
  9. Monitor for adverse and paradoxical effects after administration and escalate promptly when abnormal response occurs.
  10. Document safety checks, clarifications, and response outcomes in the medical record.

Common Errors

  • Using room number as identifier wrong-patient administration risk.
  • Administering with incomplete/unclear order or missing PRN indication unsafe decision-making.
  • Preparing medications for multiple patients simultaneously cross-patient mix-up risk.
  • Ignoring interruptions during preparation increased dosing and labeling errors.